OBJECTIVE: To determine whether the patterns of distribution of histological effects of vaporized perfluorohexane (PFH) and partial liquid ventilation (PLV) differ significantly in acute lung injury. DESIGN AND SETTING: Experimental study in an animal research laboratory. SUBJECTS: Eighteen pigs. INTERVENTIONS: After induction of acute lung injury by means of infusion of oleic acid animals were randomly assigned to PFH, PLV, or gas ventilation (GV) groups. Six hours thereafter animals were killed, and lung tissue samples were taken for analysis. MEASUREMENTS AND RESULTS: Histopathological analysis revealed less damage with PFH than with GV or PLV in the nondependent and central regions. PFH and PLV showed less injury in the dependent regions than GV. GV and PFH were associated with less histological damage in the nondependent than the dependent regions, whereas PLV presented the opposite pattern. Morphometric analysis showed increased aeration in nondependent than dependent regions with PFH and GV. PLV led to more aeration in the periphery than in central areas. CONCLUSIONS: PFH was associated with a more homogeneous attenuation of alveolar damage across the lungs, although this therapy had more pronounced effects in nondependent zones. PLV showed the opposite pattern, with more important reduction in alveolar damage in dependent lung regions. Interestingly, reduction in alveolar damage with PFH was as effective as with PLV in dependent zones. Our findings suggest that vaporized perfluorocarbon could be advantageous as adjunctive therapy in the treatment of acute lung injury.
OBJECTIVE: To determine whether the patterns of distribution of histological effects of vaporized perfluorohexane (PFH) and partial liquid ventilation (PLV) differ significantly in acute lung injury. DESIGN AND SETTING: Experimental study in an animal research laboratory. SUBJECTS: Eighteen pigs. INTERVENTIONS: After induction of acute lung injury by means of infusion of oleic acid animals were randomly assigned to PFH, PLV, or gas ventilation (GV) groups. Six hours thereafter animals were killed, and lung tissue samples were taken for analysis. MEASUREMENTS AND RESULTS: Histopathological analysis revealed less damage with PFH than with GV or PLV in the nondependent and central regions. PFH and PLV showed less injury in the dependent regions than GV. GV and PFH were associated with less histological damage in the nondependent than the dependent regions, whereas PLV presented the opposite pattern. Morphometric analysis showed increased aeration in nondependent than dependent regions with PFH and GV. PLV led to more aeration in the periphery than in central areas. CONCLUSIONS:PFH was associated with a more homogeneous attenuation of alveolar damage across the lungs, although this therapy had more pronounced effects in nondependent zones. PLV showed the opposite pattern, with more important reduction in alveolar damage in dependent lung regions. Interestingly, reduction in alveolar damage with PFH was as effective as with PLV in dependent zones. Our findings suggest that vaporized perfluorocarbon could be advantageous as adjunctive therapy in the treatment of acute lung injury.
Authors: M Ragaller; J Bleyl; U Tschö; T Winkler; M Regner; S Rasche; T Koch; M Albrecht Journal: Intensive Care Med Date: 2001-05 Impact factor: 17.440
Authors: Robert M Kacmarek; Herbert P Wiedemann; Philip T Lavin; Mark K Wedel; Ahmet S Tütüncü; Arthur S Slutsky Journal: Am J Respir Crit Care Med Date: 2005-10-27 Impact factor: 21.405
Authors: T Koch; M Ragaller; D Haufe ; A Hofer; M Grosser; D M Albrecht; M Kotzsch; T Luther Journal: Anesthesiology Date: 2001-01 Impact factor: 7.892
Authors: Gregor I Kemming; Michael Flondor; Anja Hanser; Sabine Pallivathukal; Markus Holtmannspötter; Florian F Kneisel; Daniel A Reuter; Hille Kisch-Wedel; Bernhard Zwissler Journal: Anesthesiology Date: 2005-09 Impact factor: 7.892
Authors: Peter N Cox; Helena Frndova; Ove Karlsson; Stephanie Holowka; Charles A Bryan Journal: Intensive Care Med Date: 2003-09-13 Impact factor: 17.440
Authors: Bernardo Yáñez-Soto; Brian C Leonard; Vijay Krishna Raghunathan; Nicholas L Abbott; Christopher J Murphy Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: P M Spieth; A Güldner; A R Carvalho; M Kasper; P Pelosi; S Uhlig; T Koch; M Gama de Abreu Journal: Br J Anaesth Date: 2011-06-07 Impact factor: 11.719
Authors: Alexander Ziebart; Erik K Hartmann; Rainer Thomas; Tanghua Liu; Bastian Duenges; Arno Schad; Marc Bodenstein; Serge C Thal; Matthias David Journal: Respir Res Date: 2014-09-06
Authors: Luciana M Camilo; Mariana B Ávila; Luis Felipe S Cruz; Gabriel C M Ribeiro; Peter M Spieth; Andreas A Reske; Marcelo Amato; Antonio Giannella-Neto; Walter A Zin; Alysson R Carvalho Journal: PLoS One Date: 2014-11-10 Impact factor: 3.240
Authors: Erik K Hartmann; Alexander Ziebart; Rainer Thomas; Tanghua Liu; Arno Schad; Martha Tews; Bernd Moosmann; Jens Kamuf; Bastian Duenges; Serge C Thal; Matthias David Journal: BMC Pulm Med Date: 2015-02-07 Impact factor: 3.317